Latest News and Press Releases
Want to stay updated on the latest news?
-
Dallas, Texas, April 27, 2026 (GLOBE NEWSWIRE) -- Seven attorneys at Goranson Bain Ausley – one of the largest family law firms in Texas – have been named to D Magazine's 2026 'Best Lawyers in...
-
- Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise gene editing in the CNS delivered via a single AAV - Poster presentations...
-
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP alerts investors in Alight, Inc. (NYSE: ALIT) of a pending securities class action. Class Period: November 12, 2024 through...
-
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- IMPORTANT DATE: May 29, 2026. Investors who purchased Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026...
-
Auddia Announces Closing of $12 Million Public Offering
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In B&W (BW) To Contact Him Directly To Discuss Their Options If you purchased or...
-
SOMERVILLE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today...
-
Zen Media: generative AI now gives PR teams citation-level measurement; Answer Share and prompt coverage replace impressions as the PR scorecard.
-
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
-
Block & Leviton announces a securities fraud lawsuit has been filed against SES AI Corp. Investors who lost money in $SES stock should contact the firm.